Wilgus TA. Immune cells in the healing skin wound: influential players at each stage of repair. Pharmacol Res. 2008;58(2):112–6. https://doi.org/10.1016/j.phrs.2008.07.009.
CAS
Article
PubMed
Google Scholar
Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007;81(1):1–5. https://doi.org/10.1189/jlb.0306164.
CAS
Article
PubMed
Google Scholar
Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A. HMGB1: endogenous danger signaling. Mol Med. 2008;14(7–8):476–84. https://doi.org/10.2119/2008-00034.Klune.
CAS
PubMed
PubMed Central
Google Scholar
• Millar NL, O'Donnell C, McInnes IB, Brint E. Wounds that heal and wounds that don’t—the role of the IL-33/ST2 pathway in tissue repair and tumorigenesis. Semin Cell Dev Biol. 2017;61:41–50. This is an informative review article on IL-33 signaling and the role of this pathway in the repair of multiple tissue types. https://doi.org/10.1016/j.semcdb.2016.08.007.
CAS
Article
PubMed
Google Scholar
Ranzato E, Patrone M, Pedrazzi M, Burlando B. HMGb1 promotes scratch wound closure of HaCaT keratinocytes via ERK1/2 activation. Mol Cell Biochem. 2009;332(1–2):199–205. https://doi.org/10.1007/s11010-009-0192-4.
CAS
Article
PubMed
Google Scholar
Straino S, Di Carlo A, Mangoni A, De Mori R, Guerra L, Maurelli R, et al. High-mobility group box 1 protein in human and murine skin: involvement in wound healing. J Invest Dermatol. 2008;128(6):1545–53. https://doi.org/10.1038/sj.jid.5701212.
CAS
Article
PubMed
Google Scholar
Ashcroft GS, Dodsworth J, van Boxtel E, Tarnuzzer RW, Horan MA, Schultz GS, et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med. 1997;3(11):1209–15. https://doi.org/10.1038/nm1197-1209.
CAS
Article
PubMed
Google Scholar
Ashcroft GS, Greenwell-Wild T, Horan MA, Wahl SM, Ferguson MW. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol. 1999;155(4):1137–46. https://doi.org/10.1016/S0002-9440(10)65217-0.
CAS
Article
PubMed
PubMed Central
Google Scholar
Ashcroft GS, Mills SJ, Lei K, Gibbons L, Jeong MJ, Taniguchi M, et al. Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J Clin Invest. 2003;111(9):1309–18. https://doi.org/10.1172/JCI16288.
CAS
Article
PubMed
PubMed Central
Google Scholar
Shin JU, Noh JY, Lee JH, Lee WJ, Yoo JS, Kim JY, et al. In vivo relative quantitative proteomics reveals HMGB1 as a downstream mediator of oestrogen-stimulated keratinocyte migration. Exp Dermatol. 2015;24(6):478–80. https://doi.org/10.1111/exd.12713.
CAS
Article
PubMed
Google Scholar
Ranzato E, Patrone M, Pedrazzi M, Burlando B. Hmgb1 promotes wound healing of 3T3 mouse fibroblasts via RAGE-dependent ERK1/2 activation. Cell Biochem Biophys. 2010;57(1):9–17. https://doi.org/10.1007/s12013-010-9077-0.
CAS
Article
PubMed
Google Scholar
Mitola S, Belleri M, Urbinati C, Coltrini D, Sparatore B, Pedrazzi M, et al. Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J Immunol. 2006;176(1):12–5. https://doi.org/10.4049/jimmunol.176.1.12.
CAS
Article
PubMed
Google Scholar
Hirth DA, Singer AJ, Clark RA, McClain SA. Histopathologic staining of low temperature cutaneous burns: comparing biomarkers of epithelial and vascular injury reveals utility of HMGB1 and hematoxylin phloxine saffron. Wound Repair Regen. 2012;20(6):918–27. https://doi.org/10.1111/j.1524-475X.2012.00847.x.
Article
PubMed
Google Scholar
Lanier ST, McClain SA, Lin F, Singer AJ, Clark RA. Spatiotemporal progression of cell death in the zone of ischemia surrounding burns. Wound Repair Regen. 2011;19(5):622–32. https://doi.org/10.1111/j.1524-475X.2011.00725.x.
Article
PubMed
PubMed Central
Google Scholar
McNamara AR, Zamba KD, Sokolich JC, Jaskille AD, Light TD, Griffin MA, et al. Apoptosis is differentially regulated by burn severity and dermal location. J Surg Res. 2010;162(2):258–63. https://doi.org/10.1016/j.jss.2009.01.038.
Article
PubMed
Google Scholar
Singer AJ, McClain SA, Taira BR, Guerriero JL, Zong W. Apoptosis and necrosis in the ischemic zone adjacent to third degree burns. Acad Emerg Med. 2008;15(6):549–54. https://doi.org/10.1111/j.1553-2712.2008.00115.x.
Article
PubMed
Google Scholar
Holmes CJ, Plichta JK, Gamelli RL, Radek KA. Burn injury alters epidermal cholinergic mediators and increases HMGB1 and caspase 3 in autologous donor skin and burn margin. Shock. 2017;47(2):175–83. https://doi.org/10.1097/SHK.0000000000000752.
CAS
Article
PubMed
PubMed Central
Google Scholar
Marchetti C, Di Carlo A, Facchiano F, Senatore C, De Cristofaro R, Luzi A, et al. High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV. Diabetologia. 2012;55(1):236–44. https://doi.org/10.1007/s00125-011-2213-6.
CAS
Article
PubMed
Google Scholar
Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002;106(22):2781–6. https://doi.org/10.1161/01.CIR.0000039526.42991.93.
Article
PubMed
Google Scholar
Sinagra T, Merlo S, Spampinato SF, Pasquale RD, Sortino MA. High mobility group box 1 contributes to wound healing induced by inhibition of dipeptidylpeptidase 4 in cultured keratinocytes. Front Pharmacol. 2015;6:126.
Article
PubMed
PubMed Central
Google Scholar
Marfella R, Sasso FC, Rizzo MR, Paolisso P, Barbieri M, Padovano V, et al. Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes. Exp Diabetes Res. 2012;2012:892706.
Article
PubMed
PubMed Central
Google Scholar
Schurmann C, Linke A, Engelmann-Pilger K, Steinmetz C, Mark M, Pfeilschifter J, et al. The dipeptidyl peptidase-4 inhibitor linagliptin attenuates inflammation and accelerates epithelialization in wounds of diabetic ob/ob mice. J Pharmacol Exp Ther. 2012;342(1):71–80. https://doi.org/10.1124/jpet.111.191098.
Article
PubMed
Google Scholar
Wilgus TA. Regenerative healing in fetal skin: a review of the literature. Ostomy Wound Manage. 2007;53(6):16–31.
PubMed
Google Scholar
Walmsley GG, Maan ZN, Wong VW, Duscher D, Hu MS, Zielins ER, et al. Scarless wound healing: chasing the holy grail. Plast Reconstr Surg. 2015;135(3):907–17. https://doi.org/10.1097/PRS.0000000000000972.
CAS
Article
PubMed
Google Scholar
Dardenne AD, Wulff BC, Wilgus TA. The alarmin HMGB-1 influences healing outcomes in fetal skin wounds. Wound Repair Regen. 2013;21(2):282–91. https://doi.org/10.1111/wrr.12028.
Article
PubMed
PubMed Central
Google Scholar
Zhang Q, O'Hearn S, Kavalukas SL, Barbul A. Role of high mobility group box 1 (HMGB1) in wound healing. J Surg Res. 2011.
Ali S, Mohs A, Thomas M, Klare J, Ross R, Schmitz ML, et al. The dual function cytokine IL-33 interacts with the transcription factor NF-kappaB to dampen NF-kappaB-stimulated gene transcription. J Immunol. 2011;187(4):1609–16. https://doi.org/10.4049/jimmunol.1003080.
CAS
Article
PubMed
Google Scholar
Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L, et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A. 2007;104(1):282–7. https://doi.org/10.1073/pnas.0606854104.
CAS
Article
PubMed
Google Scholar
Chackerian AA, Oldham ER, Murphy EE, Schmitz J, Pflanz S, Kastelein RA. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol. 2007;179(4):2551–5. https://doi.org/10.4049/jimmunol.179.4.2551.
CAS
Article
PubMed
Google Scholar
Palmer G, Lipsky BP, Smithgall MD, Meininger D, Siu S, Talabot-Ayer D, et al. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. Cytokine. 2008;42(3):358–64. https://doi.org/10.1016/j.cyto.2008.03.008.
CAS
Article
PubMed
Google Scholar
Kakkar R, Lee RT. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov. 2008;7(10):827–40. https://doi.org/10.1038/nrd2660.
CAS
Article
PubMed
PubMed Central
Google Scholar
Moussion C, Ortega N, Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’? PLoS One. 2008;3(10):e3331. https://doi.org/10.1371/journal.pone.0003331.
Article
PubMed
PubMed Central
Google Scholar
Pichery M, Mirey E, Mercier P, Lefrancais E, Dujardin A, Ortega N, et al. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol. 2012;188(7):3488–95. https://doi.org/10.4049/jimmunol.1101977.
CAS
Article
PubMed
Google Scholar
Kuchler AM, Pollheimer J, Balogh J, Sponheim J, Manley L, Sorensen DR, et al. Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. Am J Pathol. 2008;173(4):1229–42. https://doi.org/10.2353/ajpath.2008.080014.
CAS
Article
PubMed
PubMed Central
Google Scholar
Yin H, Li X, Hu S, Liu T, Yuan B, Gu H, et al. IL-33 accelerates cutaneous wound healing involved in upregulation of alternatively activated macrophages. Mol Immunol. 2013;56(4):347–53. https://doi.org/10.1016/j.molimm.2013.05.225.
CAS
Article
PubMed
Google Scholar
• Rak GD, Osborne LC, Siracusa MC, Kim BS, Wang K, Bayat A, et al. IL-33-dependent group 2 innate lymphoid cells promote cutaneous wound healing. J Invest Dermatol. 2016;136(2):487–496. This paper demonstrates an important role for IL-33 in the recruitment of ILC2 cells during skin repair. https://doi.org/10.1038/JID.2015.406.
CAS
Article
PubMed
PubMed Central
Google Scholar
• Oshio T, Komine M, Tsuda H, Tominaga SI, Saito H, Nakae S, et al. Nuclear expression of IL-33 in epidermal keratinocytes promotes wound healing in mice. J Dermatol Sci. 2017;85(2):106–114. This study suggests opposing nuclear and extracellular activities of IL-33 in wound healing. https://doi.org/10.1016/j.jdermsci.2016.10.008.
CAS
Article
PubMed
Google Scholar
Khanna S, Biswas S, Shang Y, Collard E, Azad A, Kauh C, et al. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS One. 2010;5(3):e9539. https://doi.org/10.1371/journal.pone.0009539.
Article
PubMed
PubMed Central
Google Scholar
Mirza RE, Fang MM, Ennis WJ, Koh TJ. Blocking interleukin-1beta induces a healing-associated wound macrophage phenotype and improves healing in type 2 diabetes. Diabetes. 2013;62(7):2579–87. https://doi.org/10.2337/db12-1450.
CAS
Article
PubMed
PubMed Central
Google Scholar
Lee JS, Seppanen E, Patel J, Rodero MP, Khosrotehrani K. ST2 receptor invalidation maintains wound inflammation, delays healing and increases fibrosis. Exp Dermatol. 2016;25(1):71–4. https://doi.org/10.1111/exd.12833.
Article
PubMed
Google Scholar
Yin H, Li X, Hu S, Liu T, Yuan B, Ni Q, et al. IL-33 promotes Staphylococcus aureus-infected wound healing in mice. Int Immunopharmacol. 2013;17(2):432–8. https://doi.org/10.1016/j.intimp.2013.07.008.
CAS
Article
PubMed
Google Scholar
Li C, Li H, Jiang Z, Zhang T, Wang Y, Li Z, et al. Interleukin-33 increases antibacterial defense by activation of inducible nitric oxide synthase in skin. PLoS Pathog. 2014;10(2):e1003918. https://doi.org/10.1371/journal.ppat.1003918.
Article
PubMed
PubMed Central
Google Scholar